Irish Health Tech Startup xWave Secures NHS Contract and Launches €3M Funding Drive
Ireland’s xWave Technologies has made significant strides in the healthcare technology sector, securing a major contract with eight NHS trusts in the northeast of England and launching a €3 million funding campaign to expand its operations. The Dublin-based startup, headquartered at NovaUCD, is leveraging artificial intelligence to address challenges in diagnostic workflows, aiming to reduce patient waiting lists and improve healthcare efficiency.
NHS Contract Details
The contract, announced in April 2025, marks xWave’s first competitive UK tender. It will see the company provide its clinical decision support (CDS) software to general practitioners (GPs) across the northeast of England, serving approximately three million patients. The software is designed to help GPs select the most appropriate imaging tests for patients, streamlining the diagnostic process and reducing delays.
“This contract win is a validation of the value that xWave brings in helping reduce patient waiting lists and easing pressures on health services,” said Mitchell O’Gorman, CEO of xWave Technologies. The company’s technology aligns with the NHS’s focus on improving access to care and optimizing resource allocation.
Technology and Impact
xWave’s CDS software uses AI to assist clinicians in making informed decisions about imaging referrals. By prioritizing the “best test first,” the platform aims to ensure patients receive timely and accurate diagnoses. This approach not only improves patient outcomes but also alleviates strain on radiology departments, which often face high workloads and backlogs.
The startup’s solution has already demonstrated measurable results. In 2025, xWave reported annual recurring revenue of €500,000, underscoring its growing market relevance. The company’s focus on AI-driven innovation positions it to address broader challenges in healthcare systems globally.
Funding Campaign and Expansion Plans
To scale its operations, xWave has initiated a €3 million crowdfunding campaign on the Spark Crowdfunding platform. The round has already raised over €600,000 from existing shareholders, with the goal of accelerating growth into new markets. O’Gorman highlighted the importance of the funding: “We want to bring this vital solution to new markets with this funding round while further developing our AI capabilities.”
The company’s expansion strategy includes enhancing its AI algorithms and exploring partnerships beyond the UK. With the NHS contract as a foundational milestone, xWave aims to establish itself as a leader in health tech innovation.
Future Prospects
The success of xWave’s NHS contract and funding drive reflects broader trends in healthcare technology, where AI is increasingly being adopted to address systemic inefficiencies. As the demand for digital health solutions grows, startups like xWave are poised to play a critical role in shaping the future of patient care.
For investors and industry observers, xWave’s journey offers a case study in how agile, tech-driven companies can navigate complex healthcare landscapes. With its focus on scalability and innovation, the startup is well-positioned to capitalize on emerging opportunities in the global health tech market.